Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04697576
Status:
RECRUITING
Last Update Posted:
2023-07-18
First Post:
2021-01-05
Brief Title:
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
Sponsor:
Carlo Contreras
Organization:
Ohio State University Comprehensive Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Clinical Stage I Cutaneous Melanoma AJCC v8 |
| Clinical Stage IA Cutaneous Melanoma AJCC v8 |
| Clinical Stage IB Cutaneous Melanoma AJCC v8 |
| Clinical Stage II Cutaneous Melanoma AJCC v8 |
| Clinical Stage IIA Cutaneous Melanoma AJCC v8 |
| Clinical Stage IIB Cutaneous Melanoma AJCC v8 |
| Clinical Stage IIC Cutaneous Melanoma AJCC v8 |
| Clinical Stage IV Cutaneous Melanoma AJCC v8 |
| Metastatic Melanoma |
Keywords: